Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer.
about
Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineDifferential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxelTaxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review.Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic reviewDecision-making tools to assist prognosis and treatment choices in early breast cancer: a review.Inconsistent selection and definition of local and regional endpoints in breast cancer research.
P2860
Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Randomized, phase III trial of ...... h node-positive breast cancer.
@en
Randomized, phase III trial of ...... h node-positive breast cancer.
@nl
type
label
Randomized, phase III trial of ...... h node-positive breast cancer.
@en
Randomized, phase III trial of ...... h node-positive breast cancer.
@nl
prefLabel
Randomized, phase III trial of ...... h node-positive breast cancer.
@en
Randomized, phase III trial of ...... h node-positive breast cancer.
@nl
P2093
P356
P1476
Randomized, phase III trial of ...... h node-positive breast cancer.
@en
P2093
Alejandro Tres
Derek Cooper
Frans Erdkamp
Jacob Wals
Judith M Bliss
Justine A Reise
Katie Wilkinson
Lucy S Kilburn
Marc Espie
Marina W K Thomas
P304
P356
10.1200/JCO.2010.32.7254
P407
P577
2011-07-18T00:00:00Z